Stability and Dissolution of Lozenge and Emulsion Formulations of Metronidazole Benzoate
Author(s): Fan Bin, Stewart James T, White Catherine A
Issue: Mar/Apr 2001 - Compounding for Animals
View All Articles in Issue
Page(s): 153-156
Download in electronic PDF format for $75
Abstract: Chicken-flavored glycerinated gelatin candy-based lozenges
and oil-in-water emulsions of metronidazole benzoate were prepared
for veterinary use. The stability and dissolution of the
lozenges and emulsions were investigated via a high-pressure
(performance) liquid chromatography (HPLC) assay. The separation
and quantitation of metronidazole benzoate were
achieved on a Phenomenex IB-SIL 5 C8 column (250 x 4.6 mm,
id) at ambient temperature, with a 55:45 v/v pH 7.0 phosphate
buffer-acetonitrile mobile phase at a flow rate of 1.0 mL/min.
Tinidazole was used as the internal standard. A sample of
metronidazole benzoate from the lozenge and emulsion was prepared
for assay by dissolving one lozenge or 1 g of the emulsion
in 50:50 v/v methanol-water solution, and that sample was
filtered through a 0.2 µm membrane filter before assay. The chromatogram
was monitored with ultraviolet detection at 230 nm.
The HPLC separation of metronidazole benzoate was achieved
in less than 10 minutes; sensitivity was in the range of 10
ng/mL. This method can be used to separate metronidazole and
benzoic acid, which are degradation products of metronidazole
benzoate, and demonstrated linearity for metronidazole benzoate
in the range of 0.01 to 100 µg/mL. Accuracy and precision
were < 1.0% and < 0.54%, respectively. The limit of quantitation
was 10 ng/mL, and the limit of detection was 0.01
ng/mL, based on a signal-to-noise ratio of 3 and a 20 µL injection.
The recoveries of metronidazole benzoate from the
lozenge and emulsion were 98% ± 4% and 99% ± 2%, respectively.
Stability testing of the new formulations was performed
at ambient temperature and at 4°C. Dissolution testing used the
USP paddle method at 37ºC and 100 rpm in simulated gastric
fluid without pepsin. Both formulations were stable at ambient
temperature and at 4°C. Metronidazole benzoate is completely
released from the lozenge and emulsion formulations
based on dissolution T50% values of 4.2 and 24 minutes and T90%
values of 12.8 and 83 minutes, respectively.
Related Keywords:
metronitdazole, metronitdazole emulsion, metronitdazole lozenge, metronitdazole stability
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Stability and Dissolution of Lozenge and Emulsion Formulations of Metronidazole Benzoate
Fan Bin, Stewart James T, White Catherine A
|
Mar/Apr 2001
Pg. 153-156
|
The Basics of Compounding Emulsions, Part 2
Allen Loyd V Jr
|
May/Jun 2001
Pg. 198-201
|
The Basics of Compounding: Compounding Hard, Soft and Chewable Troches/Lozenges/Drops
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 461-465
|
Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils
Boonme Prapaporn, Maneenuan Duangkhae
|
Nov/Dec 2014
Pg. 516-519
|
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate
Wu George, Yeung Stanley, Chen Frank
|
Jan/Feb 2017
Pg. 66-75
|
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride
Wu George, Yeung Stanley, Chen Frank
|
Jan/Feb 2017
Pg. 76-82
|
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride
Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
|
Jan/Feb 2018
Pg. 86-94
|
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
|
Nov/Dec 2008
Pg. 558-564
|
Benzoate or Not to Benzoate: Cats Are the Question, To
Davidson Gigi S
|
Mar/Apr 2001
Pg. 89-90
View Sample |
Experimenting with a New Emulsifying Agent (Tahini) in Mineral Oil Emulsion
Al-Achi Antoine, Greenwood Robert, Akin-Isijola Austin
|
Jul/Aug 2000
Pg. 315-317
|
Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspension
Atkins Julia R, Lull Melinda E, Decker Andrew S, Hutchinson David J
|
Jul/Aug 2018
Pg. 326-328
|
Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
|
Mar/Apr 2021
Pg. 169-175
|
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection
Wu George, Powers Dan, Yeung Stanley, Chen Frank
|
Jan/Feb 2018
Pg. 76-85
|
Tablet and Lozenge Binders, Featured Excipient:
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 471-473
|
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Schotik Debora
|
Jan/Feb 2001
Pg. 9-12
|
Formulation and Stability of Solutions
Akers Michael J
|
Jan/Feb 2016
Pg. 41-45
|
Extemporaneous Lozenge Formulations
Palmer Henry A, Semprebon Marc
|
Jan/Feb 1998
Pg. 71-72
|
The Basics of Compounding Emulsions, Part 1
Allen Loyd V Jr
|
Mar/Apr 2001
Pg. 120-123
|
Acacia and Mineral Oil Emulsion NF
Al-Achi Antoine, Mosley Anita, Patlolla Swapna
|
Jan/Feb 2006
Pg. 44
|
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition
Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
|
Sep/Oct 2014
Pg. 427-431
|
Return to Top |